{"schema_version":"secwatch.filing_event.v1","accession":"0001420800-24-000026","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.408480+00:00","generated_at":"2026-05-30T04:27:08.451339+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Enovis Q3 net sales $505M (+21% reported), adj. EPS $0.73 beat; raises FY adj. EPS guidance to $2.75-2.80","bullets":["Q3 net sales $505M, up 21% reported/6% comparable; Recon sales +57% reported/9% comparable.","Net loss from continuing ops $0.61/sh; adjusted EPS $0.73, up 30% YoY.","Adjusted EBITDA $90M (17.9% of sales), margin +220 bps vs prior year.","FY2024 guidance: revenue ~$2.10B; adj. EBITDA $373-378M; adj. EPS raised from $2.62-2.77 to $2.75-2.80.","Lima acquisition contributed to Recon growth; integration progress cited."],"urls":{"canonical":"https://secwatch.observer/filing/0001420800-24-000026","json":"https://secwatch.observer/filing/0001420800-24-000026.json","markdown":"https://secwatch.observer/filing/0001420800-24-000026.md","text":"https://secwatch.observer/filing/0001420800-24-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000142080024000026/0001420800-24-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000142080024000026/cfx-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:27:08.451339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}